These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 16928654)
1. Comparision of the apoptotic effects on lymphoblasts and on increase of myeloid lineage cells of a short-time, high-dose methylprednisolone and the conventional-dose prednisolone treatments in children with acute lymphoblastic leukemia. Erduran E; Tekelioglu Y; Karakas T; Gedik Y; Mert FM Pediatr Hematol Oncol; 2006; 23(7):587-98. PubMed ID: 16928654 [TBL] [Abstract][Full Text] [Related]
2. Proliferation of myeloid lineage cells and apoptosis of lymphoblastic leukemic cells induced by short-course high-dose methylprednisolone in patients with acute lymphoblastic leukemia. Yildiran A; Erduran E; Tekelioğlu Y; Dilber E; Gedik Y Turk J Pediatr; 2002; 44(2):116-21. PubMed ID: 12026198 [TBL] [Abstract][Full Text] [Related]
3. The effect of high-dose methylprednisolone combined chemotherapy on CD34-positive cells in acute lymphoblastic leukemia. Tuncer AM; Hiçsönmez G; Gümrük F; Albayrak D; Duru F; Güzel E; Sayli T Hematol Pathol; 1994; 8(4):169-75. PubMed ID: 7532164 [TBL] [Abstract][Full Text] [Related]
4. The effect of short-course high-dose corticosteroid therapy on peripheral blood CD34+ progenitor cells in children with acute leukemia. Cetin M; Hiçsönmez G; Tuncer AM; Kansu E; Canpynar H Exp Hematol; 1996 Aug; 24(10):1191-4. PubMed ID: 8765493 [TBL] [Abstract][Full Text] [Related]
5. Bone mineral density and serum bone turnover markers in survivors of childhood acute lymphoblastic leukemia: comparison of megadose methylprednisolone and conventional-dose prednisolone treatments. Alikasifoglu A; Yetgin S; Cetin M; Tuncer M; Gumruk F; Gurgey A; Yordam N Am J Hematol; 2005 Oct; 80(2):113-8. PubMed ID: 16184587 [TBL] [Abstract][Full Text] [Related]
6. The effect of short-course high-dose methylprednisolone on peripheral blood CD34+ progenitor cells of children with acute leukemia during remission induction therapy. Tunç B; Oner AF; Hiçsönmez G Turk J Pediatr; 2002; 44(1):1-4. PubMed ID: 11858371 [TBL] [Abstract][Full Text] [Related]
7. The role of short course of high-dose methylprednisolone in children with acute myeloblastic leukemia (FAB M2) presented with myeloid tumor. Hiçsönmez G; Cetin M; Aslan D; Ozyürek E Pediatr Hematol Oncol; 2003; 20(5):373-9. PubMed ID: 12775535 [TBL] [Abstract][Full Text] [Related]
8. Myeloprotective effect of short-course high-dose methylprednisolone treatment before consolidation therapy in children with acute myeloblastic leukemia. Elmas SA; Cetin M; Tuncer M; Hiçsönmez G Am J Hematol; 2005 Sep; 80(1):1-5. PubMed ID: 16138333 [TBL] [Abstract][Full Text] [Related]
9. The effect of short course high dose methylprednisolon therapy on fibrinogen level in children with acute lymphoblastic leukemia. A preliminary study. Toksöz H; Unal S; Kirazli S; Gürgey A Leuk Res; 2004 May; 28(5):533-5. PubMed ID: 15068907 [TBL] [Abstract][Full Text] [Related]
10. Clinical importance of myeloid-antigen expression in acute lymphoblastic leukemia of childhood. Wiersma SR; Ortega J; Sobel E; Weinberg KI N Engl J Med; 1991 Mar; 324(12):800-8. PubMed ID: 1997852 [TBL] [Abstract][Full Text] [Related]
11. In vitro determination of the apoptotic effect of heparin on lymphoblasts using DNA analysis and measurements of Fas and Bcl-2 proteins by flow cytometry. Erduran E; Tekelioglu Y; Gedik Y; Bektaş I; Hacisalihoglu S Pediatr Hematol Oncol; 2004; 21(5):383-91. PubMed ID: 15205081 [TBL] [Abstract][Full Text] [Related]
12. The effect of steroid on myeloid leukemic cells: the potential of short-course high-dose methylprednisolone treatment in inducing differentiation, apoptosis and in stimulating myelopoiesis. Hiçsönmez G Leuk Res; 2006 Jan; 30(1):60-8. PubMed ID: 15979702 [TBL] [Abstract][Full Text] [Related]
13. Effect of short course high dose methylprednisolone on endothelin-1 and nitric oxide in children with acute lymphoblastic leukemia: a preliminary study. Ozyurek E; Okur H; Gurgey A Ann Hematol; 2006 Jan; 85(1):55-7. PubMed ID: 16258745 [TBL] [Abstract][Full Text] [Related]
14. Characterization of CD34+, CD13+, CD33- cells, a rare subset of immature human hematopoietic cells. Gaipa G; Coustan-Smith E; Todisco E; Maglia O; Biondi A; Campana D Haematologica; 2002 Apr; 87(4):347-56. PubMed ID: 11940478 [TBL] [Abstract][Full Text] [Related]
15. Effect of short-course, high-dose steroid therapy in a child with myelodysplastic syndrome. Hiçsönmez G; Tunç B; Olcay L; Tuncer MA Pediatr Hematol Oncol; 2001 Dec; 18(8):525-9. PubMed ID: 11764102 [TBL] [Abstract][Full Text] [Related]
16. Significance of the complete clearance of peripheral blasts after 7 days of prednisolone treatment in children with acute lymphoblastic leukemia: the Tokyo Children's Cancer Study Group Study L99-15. Manabe A; Ohara A; Hasegawa D; Koh K; Saito T; Kiyokawa N; Kikuchi A; Takahashi H; Ikuta K; Hayashi Y; Hanada R; Tsuchida M; Haematologica; 2008 Aug; 93(8):1155-60. PubMed ID: 18519521 [TBL] [Abstract][Full Text] [Related]
17. A randomized and comparative study of intravenous immunoglobulin and mega dose methylprednisolone treatments in children with acute idiopathic thrombocytopenic purpura. Erduran E; Aslan Y; Gedik Y; Orhan F Turk J Pediatr; 2003; 45(4):295-300. PubMed ID: 14768792 [TBL] [Abstract][Full Text] [Related]
18. Study of apoptosis in peripheral blood of patients with acute lymphoblastic leukemia during induction therapy. Tsangaris GT; Moschovi M; Mikraki V; Vrachnou E; Tzortzatou-Stathopoulou F Anticancer Res; 1996; 16(5B):3133-40. PubMed ID: 8920781 [TBL] [Abstract][Full Text] [Related]
19. Immunophenotype of myeloid cells in myelodysplastic syndromes and its clinical implications. Shao Z; Chen G; Lin Z; Zhang Y; Hao Y; Chu Y; Zheng Y; Qian L; Yang T; Yang C; Feng B Chin Med J (Engl); 1998 Jan; 111(1):28-31. PubMed ID: 10322648 [TBL] [Abstract][Full Text] [Related]
20. Characteristics of patients with TEL-AML1-positive acute lymphoblastic leukemia with single or multiple fusions. Al-Sweedan SA; Neglia JP; Steiner ME; Bostrom BC; Casey T; Hirsch BA Pediatr Blood Cancer; 2007 May; 48(5):510-4. PubMed ID: 16763978 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]